News about Drug Discovery & Development

Lupin Rolls Out First Generic Version of Oracea

Lupin has unveiled the first generic version of Oracea (Doxycycline Capsules, 40 mg), in the United States.

Drug Discovery & Development | 10/04/2024 | By Aishwarya |  689

AustinPx Invests in Pharmaceutics and Manufacturing Capabilities to Boost Drug Development

The latest investments enhance AustinPx’s early phase development and manufacturing capabilities by enabling faster timelines, improved stability, and reduced risk.

Drug Discovery & Development | 09/04/2024 | By Manvi |  666

Dr Reddy's, Bayer to Market Second Brand of Vericiguat in India

Dr Reddy’s Laboratories has joined forces with Bayer to introduce a second brand of Vericiguat, a medication for chronic heart failure, to the Indian market.

Drug Discovery & Development | 08/04/2024 | By Aishwarya |  1613

Acumen Pharmaceuticals Join Hands with Lonza to Bolster Sabirnetug Production

Acumen Pharmaceuticals has signed a partnership agreement with Lonza, a global partner to the pharmaceutical, biotech, and nutraceutical markets.

Drug Discovery & Development | 05/04/2024 | By Aishwarya |  806

Aurigene Rolls Out AI and ML Assisted Drug Discovery Platform

Aurigene Pharmaceutical Services Ltd., a subsidiary of Dr Reddy’s Laboratories, has launched Aurigene. AI, an innovative platform integrating artificial intelligence.

Drug Discovery & Development | 05/04/2024 | By Aishwarya |  1177

Asahi Kasei Medical and AW Technologies Sign Agreement for TrachFlush in Japan

AW Technologies is currently in the process of medical device registration of the TrachFlush in Japan, with market launch targeted in fiscal 2024.

Drug Discovery & Development | 03/04/2024 | By Manvi |  765

Teva UK and Closed Loop Medicine Collaborates to Advance Development of Personalised Medicines

Teva UK Limited and Closed Loop Medicine Ltd have announced a strategic partnership to advance the development of personalised medicines.

Drug Discovery & Development | 26/03/2024 | By Manvi |  262

Aptamer Sciences Files IND Application for Phase 1 Clinical Trial of AST-201

Aptamer Sciences Inc. has filed for an Investigational New Drug (IND) application for the phase 1 clinical trial of AST-201 with the Korean Ministry of Food and Drug Safety

Drug Discovery & Development | 26/03/2024 | By Manvi |  1145

NeuExcell Therapeutics Hits New Milestone in Treatment of Malignant Glioma with NXL-004

NeuExcell Therapeutics has successfully given the dosing of the first patient with the first-in-class NeuroD1 gene therapy product NXL-004.

Drug Discovery & Development | 22/03/2024 | By Manvi |  502

Romaco Tecpharm Develops New ERS for Tablet Coaters

Romaco Tecpharm has announced the development of a new energy recovery system (ERS) for tablet coaters.

Drug Discovery & Development | 19/03/2024 | By Manvi |  264